Samuel Anchipolovsky is an analyst at ClearView Healthcare Partners since August 2024, with a strong foundation in healthcare management and neuroscience from The Wharton School and the University of Pennsylvania. Previously, Samuel served as an undergraduate researcher at Penn Medicine from June 2021 to May 2024 and co-directed efforts at Locust Bioventures during the same period. Other experiences include a summer analyst role at Credit Suisse and internships at Aegis Ventures and Regeneron. Additionally, Samuel was a teaching assistant at the University of Pennsylvania's College of Liberal and Professional Studies and held an internship at CareAlign. Educational qualifications include a Bachelor of Science in Economics with a focus on Healthcare Management and a Bachelor of Arts in Neuroscience, both expected to be completed in 2024, as well as a high school diploma from Bergen County Academies.